By: Kairos Ventures On: May 24, 2022 In: Portfolio News, Provivi

Provivi is pleased to be featured at this year’s World Economic Forum in the DAVOS 2022 campaign. The meeting...

Read more
By: Kairos Ventures On: May 24, 2022 In: MemVerge, Portfolio News

Intesa Sanpaolo, Italy’s largest bank, is using Optane hardware with MemVerge and Hazelcast system software to enlarge the effective...

Read more
By: Kairos Ventures On: May 13, 2022 In: MemVerge, Portfolio News

MemVerge™ announced that SeekGene has significantly reduced processing time and cost for data intensive single-cell analysis tasks using MemVerge...

Read more
By: Kairos Ventures On: May 10, 2022 In: Portfolio News, Xidas

Sampling now, micro pressure sensors are the first in a series of the world’s most highly integrated microfluidic devices,...

Read more
By: Kairos Ventures On: May 9, 2022 In: MemVerge, Portfolio News

is the first to be recognized as a double Bio-IT World Award winner. It was recognized as the Bio-IT...

Read more
By: Kairos Ventures On: May 3, 2022 In: Foldax, Portfolio News

Foldax announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial...

Read more

Axial Therapeutics announced that A. Stewart Campbell, Ph.D., chief executive officer, will participate in a panel titled “Placing Patients...

Read more
By: Kairos Ventures On: April 28, 2022 In: Amorphology, Portfolio News

Amorphology has partnered with AddiTec to develop the additive manufacturing of multi-metal gear components for robotics.

Read more

Chimera Bioengineering is having a big week. The San Francisco-based biotherapeutics company announced Thursday that it has won the Asian Fund for...

Read more
By: Kairos Ventures On: April 28, 2022 In: Delpor, Portfolio News

Delpor announced that it has initiated and dosed the first subjects in a phase 1 clinical trial of DLP-160,...

Read more